| 51 |
17976797 | The effect of single-dose tramadol on oxycodone clearance. | 2007 Nov |
2 |
| 52 |
16631290 | Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer. | 2006 Sep 30 |
2 |
| 53 |
16678548 | Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites. | 2006 May |
1 |
| 54 |
15039299 | Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. | 2004 Apr |
1 |
| 55 |
12560936 | Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. | 2003 Feb |
1 |
| 56 |
12920424 | Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. | 2003 Aug |
1 |
| 57 |
12422998 | Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases. | 2002 Oct |
5 |
| 58 |
11207001 | Morphine or oxycodone in cancer pain? | 2000 |
1 |
| 59 |
9871425 | Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. | 1998 Dec |
4 |
| 60 |
10483388 | The effects of the genetic absence and inhibition of CYP2D6 on the metabolism of codeine and its derivatives, hydrocodone and oxycodone. | 1998 Fall |
1 |
| 61 |
9352573 | Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. | 1997 Oct |
1 |
| 62 |
8477556 | Inhibition by fluoxetine of cytochrome P450 2D6 activity. | 1993 Apr |
1 |